These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6787704)

  • 1. Thyrotropin-releasing hormone improves cardiovascular function in experimental endotoxic and hemorrhagic shock.
    Holaday JW; D'Amato RJ; Faden AI
    Science; 1981 Jul; 213(4504):216-8. PubMed ID: 6787704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin releasing hormone: autonomic effects upon cardiorespiratory function in endotoxic shock.
    Holaday JW; Faden AI
    Regul Pept; 1983 Oct; 7(2):111-25. PubMed ID: 6419292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin releasing hormone improves blood pressure and survival in endotoxic shock.
    Holaday JW; Ruvio BA; Faden AI
    Eur J Pharmacol; 1981 Aug; 74(1):101-5. PubMed ID: 6797829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin releasing hormone: effects in monkeys and dogs subjected to experimental circulatory shock.
    Gurll NJ; Holaday JW; Reynolds DG; Ganes E
    Crit Care Med; 1987 Jun; 15(6):574-81. PubMed ID: 3105962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock.
    Qureshi NU; Dayao EK; Shirali S; Zukowska-Grojec Z; Hauser GJ
    Regul Pept; 1998 Sep; 75-76():215-20. PubMed ID: 9802412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of naloxone and thyrotropin-releasing hormone on plasma catecholamines, corticosterone, and arterial pressure in normal and endotoxemic rats.
    Long JB; Lake CR; Reid AA; Holaday JW
    Circ Shock; 1986; 18(1):1-10. PubMed ID: 3080257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of thyrotropin releasing hormone as a therapeutic intervention for endotoxemia.
    Brackett DJ; Schaefer CF; Lerner MR; Holaday JW; Fagraeus L; Wilson MF
    Regul Pept; 1990 Jul; 29(2-3):153-62. PubMed ID: 2120745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of naloxone on endotoxic and hemorrhagic shock in horses.
    Weld JM; Kamerling SG; Combie JD; Nugent TE; Woods WE; Oeltgen P; Tobin T
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):227-38. PubMed ID: 6739953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiorespiratory alterations produced by centrally administered thyrotropin-releasing hormone during canine endotoxin shock.
    Leffew SD; Williams CD; Janssen HF
    Circ Shock; 1987; 21(3):225-32. PubMed ID: 3105908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial metabolism during acute hemorrhagic or endotoxic shock.
    Spitzer JJ; Spitzer JA; Weng JT; Scott JC
    Adv Exp Med Biol; 1971 Oct; 23(0):267-73. PubMed ID: 5164829
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of TRH in circulatory shock and central nervous system ischemia.
    Holaday JW; Long JB; Martinez-Arizala A; Chen HS; Reynolds DG; Gurll NJ
    Ann N Y Acad Sci; 1989; 553():370-9. PubMed ID: 2497680
    [No Abstract]   [Full Text] [Related]  

  • 12. Naloxone in endotoxic shock: experimental models and clinical perspective.
    Gurll N
    Adv Shock Res; 1983; 10():63-71. PubMed ID: 6308974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin-releasing hormone (TRH) and circulatory shock.
    McIntosh TK; Faden AI
    Circ Shock; 1986; 18(3):241-58. PubMed ID: 3084122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular mechanisms of thyrotropin-releasing hormone against experimental hemorrhagic shock.
    Zheng D; Chen HS; Hu DY
    Circ Shock; 1992 Mar; 36(3):169-73. PubMed ID: 1611701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil activation, tumor necrosis factor, and survival after endotoxic and hemorrhagic shock.
    Barroso-Aranda J; Zweifach BW; Mathison JC; Schmid-Schönbein GW
    J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S23-9. PubMed ID: 8699857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone and TRH in the treatment of shock and trauma: what future roles?
    Bernton EW
    Ann Emerg Med; 1985 Aug; 14(8):729-35. PubMed ID: 3927793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triiodothyronine (T3) improves cardiovascular function during hemorrhagic shock.
    Dulchavsky SA; Lucas CE; Ledgerwood AM; Grabow D; Brown TR; Bagchi N
    Circ Shock; 1993 Jan; 39(1):68-73. PubMed ID: 8481977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pressor effect of naloxone phentolamine or cinanserine injected into the lateral cerebroventricle of rabbit with haemorrhagic or endotoxic shock].
    Wei ZY; Wang JQ; Pan XJ
    Sheng Li Xue Bao; 1988 Dec; 40(6):603-7. PubMed ID: 3249952
    [No Abstract]   [Full Text] [Related]  

  • 19. Beneficial effect of thyrotropin-releasing hormone in canine hemorrhagic shock.
    Teba L; Zakaria M; Dedhia HV; Schiebel F; Beamer KC
    Circ Shock; 1987; 21(1):51-7. PubMed ID: 2949884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental studies of hemorrhagic and endotoxic shock].
    Inazumi K; Sagara Y; Tanaka Y; Isshiki A; Ito K
    Masui; 1971 Sep; 20(10):933-4. PubMed ID: 5166797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.